Compare SPRU & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SPRU | IXHL |
|---|---|---|
| Founded | 2008 | 2001 |
| Country | United States | Australia |
| Employees | 4 | N/A |
| Industry | Auto Parts:O.E.M. | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.9M | 37.0M |
| IPO Year | 2019 | 2024 |
| Metric | SPRU | IXHL |
|---|---|---|
| Price | $1.86 | $3.24 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 42.5K | ★ 82.7K |
| Earning Date | 05-13-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 62.30 | N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $23,194,000.00 | $12,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 48.68 | N/A |
| 52 Week Low | $1.34 | $0.16 |
| 52 Week High | $6.75 | $6.39 |
| Indicator | SPRU | IXHL |
|---|---|---|
| Relative Strength Index (RSI) | 32.30 | 52.75 |
| Support Level | N/A | $2.79 |
| Resistance Level | $2.46 | $3.68 |
| Average True Range (ATR) | 0.19 | 0.14 |
| MACD | -0.01 | 0.04 |
| Stochastic Oscillator | 19.00 | 85.42 |
Spruce Power Holding Corp is an owner and operator of distributed solar energy assets across the United States (the U.S.), offering subscription-based services to home solar assets and customer contracts, making renewable energy more accessible to everyone. The Company's customers are homeowners and the Company's core solar service offerings generate revenues through, the sale of electricity generated by its home solar energy systems to homeowners, third-party contracts to sell solar renewable energy credits (SRECs) generated by the solar energy systems for fixed prices and the servicing of those agreements for other institutional owners of home solar energy systems.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.